News and Media

Latest News Release

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


Press Releases

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio, Nov. 4, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of record at the close of business on January 3, 2022.

About Cardinal Health 
Cardinal Health (NYSE: CAH) is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at

Media: Andrew Stern, and (614) 339-4678

Investors: Kevin Moran, and (614) 757-7942

SOURCE Cardinal Health

More Company News

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...


DUBLIN, Ohio — May 9, 2022— Cardinal Health (NYSE:CAH) and URAC, the nation’s largest independent health care accreditation organization, announced today an agreement to help customers of...


Revenue increased 14% to $44.8 billion GAAP1 operating loss was $97 million due to a non-cash, pre-tax goodwill impairment of $474 million in the Medical segment; GAAP diluted loss per share was $5.05


CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas, May 3, 2022—(BUSINESS WIRE)—AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have...

View all company news »

* Required Fields